Spinal Fusion Clinical Trials

Clinical trials related to Spinal Fusion Procedure

Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider Target-Controlled Infusion Models. A Randomized Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This randomized prospective study aims to compare the effects of two target-controlled infusion models, the Schnider and Eleveld models, on anesthetic depth and hemodynamic responses during anesthesia induction in adult patients undergoing spinal surgery. Patients scheduled for spinal surgery will be randomized into either the Schnider or Eleveld group. Before induction, standard monitoring will be applied, including electrocardiography, peripheral oxygen saturation, invasive arterial blood pressure monitoring, heart rate monitoring, and bispectral index monitoring. Anesthesia induction will be performed with fentanyl 2 mcg/kg, rocuronium 0.6 mg/kg, and propofol administered by target-controlled infusion with an effect-site target concentration of 3 mcg/mL according to the allocated pharmacokinetic model. Hemodynamic parameters and bispectral index values will be recorded before induction and at the 1st, 3rd, 5th, and 10th minutes after induction. Additional parameters, including time to BIS below 40, time to delta activity, burst suppression duration, total propofol dose during the first 5 minutes, need for additional propofol, hemodynamic response to intubation, vasopressor requirement within the first 10 minutes, and use of esmolol, will also be documented. The primary aim is to evaluate whether the Schnider and Eleveld models differ in terms of induction-related hemodynamic stability and anesthetic depth during the early induction period.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients scheduled for elective spinal surgery under general anesthesia

• Patients who will undergo surgery at the Neurosurgery Department of Istanbul University, Istanbul Faculty of Medicine

• Patients aged 18 years or older

• Patients who provide written informed consent to participate in the study

Locations
Other Locations
Turkey
Istanbul University
RECRUITING
Istanbul
Contact Information
Primary
Tugce Aydin Ozata, MD
tugceaydin1@gmail.com
009 0533 711 6090
Time Frame
Start Date: 2026-05-18
Estimated Completion Date: 2026-08-30
Participants
Target number of participants: 50
Treatments
Eleveld Model
Eleveld model used patients
Schnider Model
Schnider model used patients
Related Therapeutic Areas
Sponsors
Leads: Istanbul University

This content was sourced from clinicaltrials.gov